Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Regenera Pharma

Regenera Pharma
2008 FOUNDED
PRIVATE STATUS
Corporate LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Operator of a clinical stage pharmaceutical company intended to develop drugs and other related pharmaceutical products. The company's RPh201 drug is used for neurological damage caused by pathological conditions and regenerating damaged tissues enabling patients avail drugs for neurodegenerative diseases and chronic non-healing wounds.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 18 Einstein Street
  • Science Park
  • Ness-Ziona
  • Israel

+972 00-000-0000

Regenera Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Regenera Pharma‘s full profile, request access.

Request full access to PitchBook

Regenera Pharma Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Regenera Pharma‘s full profile, request access.

Request full access to PitchBook

Regenera Pharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Jordan Rubinson Chief Executive Officer
Sharon Falach-Kovalsky Chief Financial Officer
Zadik Hazan MD Founder, Director and CSO

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Regenera Pharma Board Members (1)

Name Representing Role Since Contact
Info
0000000 000000000 00.0 Canndoc Pharma Chairman 000 0000